SUPV3L1 and neoplasm: There was a significant difference (P < 0.05) in tumor mutational burden between patients in the high and low group, high expression of SUPV3L1 and infiltration of Th2 cells and T helper cells and low expression of SLC22A17 and infiltration of Mast cells coupled with a high mutational burden (Fig. 2d).